Aging and chronic DNA damage response activate a regulatory pathway involving miR‐29 and p53

Aging is a multifactorial process that affects most of the biological functions of the organism and increases susceptibility to disease and death. Recent studies with animal models of accelerated aging have unveiled some mechanisms that also operate in physiological aging. However, little is known about the role of microRNAs (miRNAs) in this process. To address this question, we have analysed miRNA levels in Zmpste24‐deficient mice, a model of Hutchinson–Gilford progeria syndrome. We have found that expression of the miR‐29 family of miRNAs is markedly upregulated in Zmpste24−/− progeroid mice as well as during normal aging in mouse. Functional analysis revealed that this transcriptional activation of miR‐29 is triggered in response to DNA damage and occurs in a p53‐dependent manner since p53−/− murine fibroblasts do not increase miR‐29 expression upon doxorubicin treatment. We have also found that miR‐29 represses Ppm1d phosphatase, which in turn enhances p53 activity. Based on these results, we propose the existence of a novel regulatory circuitry involving miR‐29, Ppm1d and p53, which is activated in aging and in response to DNA damage.

[1]  S. Bronk,et al.  Transcriptional suppression of mir‐29b‐1/mir‐29a promoter by c‐Myc, hedgehog, and NF‐kappaB , 2010, Journal of cellular biochemistry.

[2]  O. Maes,et al.  Murine microRNAs implicated in liver functions and aging process , 2008, Mechanisms of Ageing and Development.

[3]  P. Leder,et al.  Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Lachmann,et al.  MicroRNA, mRNA, and protein expression link development and aging in human and macaque brain. , 2010, Genome research.

[5]  S. Shenouda,et al.  MicroRNA function in cancer: oncogene or a tumor suppressor? , 2009, Cancer and Metastasis Reviews.

[6]  Gregory J. Hannon,et al.  microRNAs join the p53 network — another piece in the tumour-suppression puzzle , 2007, Nature Reviews Cancer.

[7]  J. Yun,et al.  Effects of MicroRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma , 2009, Hepatology.

[8]  A. Fornace,et al.  Wip1 directly dephosphorylates gamma-H2AX and attenuates the DNA damage response. , 2010, Cancer research.

[9]  Galit Lahav,et al.  The ups and downs of p53: understanding protein dynamics in single cells , 2009, Nature Reviews Cancer.

[10]  Y. Pekarsky,et al.  Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.

[11]  David J. Chen,et al.  Genomic instability in laminopathy-based premature aging , 2005, Nature Medicine.

[12]  L. Bonetta Edible vaccines: not quite ready for prime time , 2002, Nature Medicine.

[13]  Mark M Perry,et al.  microRNA expression in the aging mouse lung , 2007, BMC Genomics.

[14]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[15]  I. Varela,et al.  Nuclear envelope defects cause stem cell dysfunction in premature-aging mice , 2008, The Journal of cell biology.

[16]  I. Varela,et al.  From Immature Lamin to Premature Aging: Molecular Pathways and Therapeutic Opportunities , 2005, Cell Cycle.

[17]  Eric C. Lai,et al.  Biological principles of microRNA-mediated regulation: shared themes amid diversity , 2008, Nature Reviews Genetics.

[18]  J. Campisi Aging, tumor suppression and cancer: high wire-act! , 2004, Mechanisms of Ageing and Development.

[19]  Jin An,et al.  MicroRNA regulation in Ames dwarf mouse liver may contribute to delayed aging , 2010, Aging cell.

[20]  Tint Lwin,et al.  microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. , 2010, Blood.

[21]  J. Hoeijmakers DNA damage, aging, and cancer. , 2009, The New England journal of medicine.

[22]  S. Cohen,et al.  microRNA functions. , 2007, Annual review of cell and developmental biology.

[23]  Ignacio Varela,et al.  Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation , 2005, Nature.

[24]  Yolanda F. Darlington,et al.  The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways , 2008, Cancer and Metastasis Reviews.

[25]  I. Varela,et al.  Premature aging in mice activates a systemic metabolic response involving autophagy induction. , 2008, Human molecular genetics.

[26]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[27]  C. López-Otín,et al.  Accelerated ageing: from mechanism to therapy through animal models , 2009, Transgenic Research.

[28]  C. Bloomfield,et al.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.

[29]  N. Shinkura,et al.  Growth Retardation, Early Death, and DNA Repair Defects in Mice Deficient for the Nucleotide Excision Repair Enzyme XPF , 2004, Molecular and Cellular Biology.

[30]  Ignacio Varela,et al.  Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging , 2008, Nature Medicine.

[31]  L. Donehower,et al.  In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. , 1993, Oncogene.

[32]  B. Gilchrest,et al.  DNA damage enhances melanogenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Caligiuri,et al.  Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. , 2010, Cancer cell.

[34]  M. Henry,et al.  MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. , 2009, European journal of cancer.

[35]  Jin-Wu Nam,et al.  miR-29 miRNAs activate p53 by targeting p85α and CDC42 , 2009, Nature Structural &Molecular Biology.

[36]  G. Lahav,et al.  Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. , 2008, Molecular cell.

[37]  V. Tarasov,et al.  Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest , 2007, Cell cycle.

[38]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[39]  M. Fraga,et al.  Nuclear envelope alterations generate an aging‐like epigenetic pattern in mice deficient in Zmpste24 metalloprotease , 2010, Aging cell.

[40]  J. Broers,et al.  Nuclear lamins: laminopathies and their role in premature ageing. , 2006, Physiological reviews.

[41]  Xiongbin Lu,et al.  The Wip1 phosphatase and Mdm2: Cracking the "Wip" on p53 stability , 2008, Cell cycle.

[42]  N. Gueven,et al.  The complexity of p53 stabilization and activation , 2006, Cell Death and Differentiation.

[43]  G. Gores,et al.  mir-29 regulates Mcl-1 protein expression and apoptosis , 2007, Oncogene.

[44]  J. Hoeijmakers,et al.  Impaired Genome Maintenance Suppresses the Growth Hormone–Insulin-Like Growth Factor 1 Axis in Mice with Cockayne Syndrome , 2006, PLoS biology.

[45]  F. Slack,et al.  A Developmental Timing MicroRNA and Its Target Regulate Life Span in C. elegans , 2005, Science.

[46]  Albert J. Fornace,et al.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.

[47]  J. Hoeijmakers,et al.  Aging and Genome Maintenance: Lessons from the Mouse? , 2003, Science.

[48]  Huating Wang,et al.  NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. , 2008, Cancer cell.

[49]  Jan Vijg,et al.  Puzzles, promises and a cure for ageing , 2008, Nature.

[50]  C. López-Otín,et al.  Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase–deficient mice , 2002, Nature Genetics.

[51]  K. Esser,et al.  Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids. , 2008, American journal of physiology. Endocrinology and metabolism.

[52]  R. Novak,et al.  DNA damage is an early event in doxorubicin-induced cardiac myocyte death. , 2006, American journal of physiology. Heart and circulatory physiology.

[53]  D. Bumcrot,et al.  MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer , 2008, Cancer biology & therapy.

[54]  R. Aharonov,et al.  hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. , 2010, Cancer research.

[55]  J. Vijg,et al.  Epigenetic factors in aging and longevity , 2009, Pflügers Archiv - European Journal of Physiology.

[56]  D. Bulavin,et al.  WIP1 phosphatase at the crossroads of cancer and aging. , 2010, Trends in biochemical sciences.

[57]  A. Grigoriev On the number of protein-protein interactions in the yeast proteome. , 2003, Nucleic acids research.

[58]  T. Kirkwood,et al.  Understanding the Odd Science of Aging , 2005, Cell.

[59]  F. Mulero,et al.  A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging , 2009, Nature Genetics.